Skip to search formSkip to main contentSkip to account menu

KP-1019

Known as: KP 1019, KP1019 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Like platinum-based chemotherapeutics, the anticancer ruthenium complex indazolium trans-[tetrachlorobis(1H-indazole)ruthenate… 
Review
2018
Review
2018
The general interest in anticancer metal-based drugs and some encouraging pharmacological results obtained at the beginning of… 
2018
2016
2016
NAMI-A and KP1019 are Ru(III)-based anti-metastatic and cytotoxic anti-cancer drugs, respectively, and have been proposed to be… 
2015
2015
Prion diseases are a group of infectious and fatal neurodegenerative disorders caused by the conformational conversion of a… 
2013
2013
Diese Masterarbeit behandelt die Reduktions-Oxidationschemie von Rutheniumkomplexen in der Gegenwart von reaktiven… 
2011
2011
Ascorbic acid has been previously discussed to have antitumor potential through its interaction with transition metal ions such… 
Highly Cited
2005
Highly Cited
2005
Purpose The ruthenium complex salt indazolium trans-[tetrachlorobisindazole-ruthenate(III)] (KP1019) and the analogous sodium…